PRESS RELEASE published on 08/15/2023 at 07:25, 3 years 2 months ago Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies
PRESS RELEASE published on 07/18/2023 at 12:26, 3 years 3 months ago Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 06/30/2023 at 07:15, 3 years 4 months ago Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions
PRESS RELEASE published on 06/26/2023 at 17:31, 3 years 4 months ago Spexis announces the results of its Annual General Meeting 2023
PRESS RELEASE published on 06/07/2023 at 07:30, 3 years 5 months ago Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances
PRESS RELEASE published on 05/30/2023 at 07:15, 3 years 5 months ago Spexis provides business update and announces financial results for the full year 2022
PRESS RELEASE published on 04/28/2023 at 07:20, 3 years 6 months ago Spexis has received temporary approval of an extension until 31 of May 2023 for the disclosure obligation in connection with the publication and the filing of the annual report 2022.
PRESS RELEASE published on 04/18/2023 at 07:15, 3 years 6 months ago Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
PRESS RELEASE published on 02/08/2023 at 07:20, 3 years 9 months ago Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®
PRESS RELEASE published on 01/25/2023 at 12:56, 3 years 9 months ago Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
Published on 11/11/2026 at 16:30, 1 hour 52 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 3 hours 57 minutes ago Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 4 hours 22 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 4 hours 22 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 13:15, 5 hours 7 minutes ago Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
Published on 11/11/2026 at 18:14, 7 minutes ago Fresenius announces intention to sell approximately 13.4 million shares in Fresenius Medical Care AG, reducing its financial investment to approximately 20 per cent
Published on 11/11/2026 at 18:00, 22 minutes ago Private Equity Holding AG: Net Asset Value as of October 31, 2026
Published on 11/11/2026 at 17:45, 37 minutes ago freenet delivers strong customer growth and high adj. free cash flow in the first nine months – 2026 guidance confirmed
Published on 11/10/2026 at 18:00, 1 day ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:35, 1 day ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
